Is OX0IN2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of OX0IN2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: OX0IN2 (CHF74.23) is trading above our estimate of fair value (CHF43.06)
Significantly Below Fair Value: OX0IN2 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for OX0IN2?
Key metric: Cannot determine the most optimal metric to value OX0IN2 stock.
The above table shows the Price to Book ratio for OX0IN2. This is calculated by dividing OX0IN2's market cap by their current
book value.
What is OX0IN2's PB Ratio?
PB Ratio
0.7x
Book
€15.61b
Market Cap
€10.83b
OX0IN2 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Book vs Industry: OX0IN2 is good value based on its Price-To-Book Ratio (0.7x) compared to the European Diversified Financial industry average (1x).
Price to Book Ratio vs Fair Ratio
What is OX0IN2's PB Ratio
compared to its
Fair PB Ratio?
This is the expected PB Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
OX0IN2 PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio
0.7x
Fair PB Ratio
n/a
Price-To-Book vs Fair Ratio: Insufficient data to calculate OX0IN2's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst OX0IN2 forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Nov ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Oct ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Sep ’25
CHF 64.89
CHF 99.00
+52.6%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Aug ’25
CHF 65.52
CHF 99.00
+51.1%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Jul ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Jun ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
May ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Apr ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Mar ’25
CHF 67.39
CHF 99.00
+46.9%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Feb ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Jan ’25
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Dec ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Nov ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Oct ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Sep ’24
CHF 70.10
CHF 99.00
+41.2%
8.2%
CHF 112.91
CHF 87.38
CHF 64.89
6
Aug ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
CHF 65.52
6
Jul ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Jun ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
May ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Apr ’24
CHF 76.80
CHF 99.00
+28.9%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Mar ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
CHF 67.39
6
Feb ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Jan ’24
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Dec ’23
n/a
CHF 99.00
0%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Nov ’23
CHF 74.23
CHF 99.00
+33.4%
8.2%
CHF 112.91
CHF 87.38
n/a
6
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.